SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and tests of key support levels dominate discussion, with many traders fearing further downside while others argue the market is oversold and see a potential bottom. Traders also point to ETF outflows, macroeconomic pressure, and exchange-security concerns as possible headwinds, but no single explanation is clearly established.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline alongside a broader crypto-market selloff has put the psychologically important $1 level in focus, with traders watching for a break and citing weak risk appetite and leveraged liquidations. The community is split between expecting further losses and treating the dip as an opportunity to accumulate.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

The FDA decision on ivonescimab for EGFR-mutated lung cancer is the focus, with traders debating whether strong progression-free-survival results and favorable updated survival trends can offset the trials missed statistical-significance threshold for overall survival. Bulls cite AstraZenecas investment and the broader drug prospects as signs of confidence, while bears see meaningful rejection risk, making the event a high-stakes, binary catalyst.

Litecoin (LTC) is a cryptocurrency . Users are able to generate LTC through the process of mining. Litecoin has a current supply of 84,000,000 with 77,827,248.80032983 in circulation. The last known price of Litecoin is 49.45346856 USD and is down -1.54 over the last 24 hours. It is currently trading on 1567 active market(s) with $228,945,256.48 traded over the last 24 hours. More information can be found at https://litecoin.org/.

Litecoin

Litecoin is drawing attention amid a sharp selloff and persistent concerns about weak price action and lost support, with traders debating whether the decline signals further downside or a buying opportunity. Some holders are accumulating and expecting a rebound, while skeptics point to LTCs repeated tendency to give back gains and lag other cryptocurrencies.

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Acadia Pharmaceuticals Inc

Acadias NUPLAZID formulation-patent appeal is the main focus after oral arguments, with the ruling pending and investors weighing the risk to long-term exclusivity. Traders cite prior favorable court rulings and managements confidence while debating the legal uncertainty; some are buying the share-price rebound, with fuller remlifanserin data also on the radar.

Amp (AMP) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Amp has a current supply of 99,720,267,351.28921674 with 89,781,193,103.18022 in circulation. The last known price of Amp is 0.00059373 USD and is down -1.77 over the last 24 hours. It is currently trading on 194 active market(s) with $2,220,767.91 traded over the last 24 hours. More information can be found at https://amp.xyz.

AMP Token

AMP is drawing attention after a sharp, high-volume price run that traders describe as unusual, with some pointing to strength during a broader crypto-market decline. The move has prompted dip-buying and breakout speculation, alongside skepticism that it may fade as a short-lived pump; no clear confirmed catalyst dominates the discussion.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: U.S. Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, U.S. Rod and Refining, Atlantic Copper, and Corporate and Other. The U.S. Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The U.S. Rod and Refining segment consists of copper conversion facilities located in North America and includes refinery and rod mills. The Atlantic Copper segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

FCX is under pressure as traders focus on weaker copper prices and reduced sales guidance amid concerns about the Grasberg ramp-up, despite an earnings beat. The community is split between seeing the decline as a buying opportunity based on long-term copper demand and warning that near-term weakness could continue.

XMAX, Inc. engages in design, marketing, and manufacture of modern home furniture. The firm offers living room, urban dining, bedroom, and nova qwik products. Its brands include Nova LifeStyle, Diamond Sofa, and Nova Living. The company was founded by Ya Ming Wong and Yuen Ching Ho in 1992 and is headquartered in Commerce, CA.

XMax Inc.

XMaxs five-year AI infrastructure agreement securing dedicated NVIDIA Blackwell computing capacity in Korea is driving attention, alongside its broader pivot from furniture toward AI inference services. Bulls see the contract and share-repurchase authorization as concrete progress, while skeptics question whether the company can execute and turn its AI plans into sustainable revenue.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,738,272,860.16806072. The last known price of Dogecoin is 0.06457313 USD and is down -2.71 over the last 24 hours. It is currently trading on 1545 active market(s) with $672,498,596.98 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a broader crypto downturn and sustained weakness, with traders warning of further losses and questioning its value and relevance. Others are buying the dip and citing chart patterns as signs of a possible rebound, leaving sentiment sharply divided.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immixs NXC-201 CAR-T results in relapsed/refractory AL amyloidosis, including new ASH presentation data, are driving attention, with bullish traders emphasizing responses and safety as support for a future BLA. The optimism is tempered by concerns over financing dilution, a longer regulatory timeline, and weak biotech sentiment, while traders also debate short interest and the stocks decline.

statis crypto Watchlist

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Next Billion-Dollar Defense Technology Opportunity: AI-Powered Explosive Threat Detection

Growing demand for smarter security systems is driving investment in AI-enabled surveillance, robotic inspection and technologies designed to help identify dangerous threats before they escalate.   New York, NY – October 15, 2026 – Artificial intelligence is changing how military forces, security agencies and critical infrastructure operators detect and respond to targeted explosive threats. From […]
The post The Next Billion-Dollar Defense Technology Opportunity: AI-Powered Explosive Threat Detection appeared first on Financial News Media.

The Future of Warfare Is Driving Billions Into Next-Generation Soldier Systems

Projected Market Growth Toward $27.4 Billion by 2035 Highlights the Long-Term Opportunity in Military Modernization   New York, NY – October 13, 2026 – The modern battlefield is changing fast, and soldiers need equipment that can keep pace. Military forces around the world are investing in advanced body armor, night vision, thermal imaging, secure communications, […]
The post The Future of Warfare Is Driving Billions Into Next-Generation Soldier Systems appeared first on Financial News Media.

The AI Defense Boom Is Just Getting Started — Billions Pour Into Next-Generation Security

Governments and critical infrastructure operators are rapidly adopting AI for threat detection, intelligence, autonomous systems and cybersecurity as global spending accelerates   New York, NY – October 6, 2026 – Artificial Intelligence is quickly moving from an emerging technology into a core part of modern defense and critical infrastructure. Militaries are using AI to process […]
The post The AI Defense Boom Is Just Getting Started — Billions Pour Into Next-Generation Security appeared first on Financial News Media.

Intellistake Technologies Corp. is an AI infrastructure and technology company developing AI agents, enterprise software and data infrastructure designed to turn real-world information into actionable intelligence, including its Austen AI platform and production AI-agent deployments. The company was founded by Hamid Salimian and Jennifer Peters on September 25, 2009 and is headquartered in Vancouver, Canada.

Intellistake Technologies Corp. - Ordinary Shares - Class A

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

ISTKF Intellistake Technologies Corp. - Ordinary Shares - Class A

Fundamentals

Latest ISTKF News